Clinical Trial Update: A Single-arm, Open-label Clinical Trial to Evaluate the Effect of SMT04 in Irritable Bowel Syndrome (IBS) [NA]

View source ↗

Summary

A single-arm, open-label clinical trial is evaluating SMT04 for irritable bowel syndrome and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Irritable Bowel Syndrome

Drugs mentioned

• SMT04

Snippet

Sponsor: Changi General Hospital | Conditions: Irritable Bowel Syndrome | NA | Status: RECRUITING